Select Page
Judith Reinsdorf

Judith Reinsdorf

Corporate Director

Director
Cornerstone Building Brands
EnPro Industries
Nurix Therapeutics
Teach for America New Jersey
NACD New Jersey

Former General Counsel
Johnson Controls, Tyco International
C. R. Bard

Judy Reinsdorf has over 15 years of experience as a C-suite executive and general counsel leading global teams in complex, multi-national companies and diverse industries. After retiring from her general counsel role, Judy joined the Alexion Pharmaceuticals board where she chaired the Nominating & Corporate Governance Committee and was a member of the Audit & Finance Committee until the company was sold in 2021. From 2013 to 2019, Judy was a director of Dun & Bradstreet, a $2 billion commercial data and analytics company, where she chaired the Nominating & Governance Committee and served on the Audit Committee and Compensation & Benefits Committee before the company was sold to private equity in a $6.9B transaction. Judy recently joined the boards of Cornerstone Building Brands, EnPro Industries, Inc. and Nurix Therapeutics, Inc.

Judy served as executive vice president and general counsel of Johnson Controls, a Fortune Global 500 leader in building products, technologies, software and services, after the 2016 merger with Tyco International. From 2007 to 2016, she was executive vice president and general counsel of Tyco during a multi-year transformation of the $37 billion industrial conglomerate. During her tenure, Judy and her team resolved sensitive FCPA and securities enforcement matters with the SEC and the DOJ and built a world-class compliance program. Before joining Tyco as general counsel, she served as general counsel and secretary of C.R. Bard, a $2 billion medical device company, which was later acquired by Becton Dickinson. Judy previously worked as associate general counsel at Pharmacia Corporation managing the litigation, employment, and deal lawyers and was tasked with leading the law department’s integration efforts following the announcement of the merger with Pfizer in 2002.

In July 2020, Judy was elected to the NACD New Jersey Board of Directors. Judy is also a member of the advisory board of Teach for America NJ. In 2019, Judy was named to WomenInc. magazine’s 2019 Most Influential Corporate Directors list. Judy and her husband live in New Jersey with their college-aged daughters.

Pin It on Pinterest